NICE recommends Novartis’ heart failure drug, Entresto

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ heart failure drug, Entresto (sacubitrial/valsartan).

Click on this link for more information.

Guideline on good pharmacovigilance practices (GVP) - Module VI – Collection, management and submiss

Guideline on requirements for the production and control of immunological veterinary medicinal produ

What’s new in Pharmacovigilance? QPPV update (Issue 2, July 2017)